IDDI at PSI 2024

June 16, 2024 — June 19, 2024

Amsterdam, Netherlands

IDDI presenting a poster on “Randomization tests in R” at the upcoming PSI 2024

The IDDI team is excited to attend the upcoming PSI 2024 and share a breakthrough via a case study in a Phase III Oncology trial. Meet our experts:

We will be happy to meet you there and discuss how our innovative statistical approaches could help enhance your drug development project!


POSTER SESSION – RANDOMIZATION TESTS IN R 

In a combined effort, Emmanuel Quinaux and Nicolas Dubois have developed a powerful R script, making the minimization method accessible and straightforward to apply. This tool not only saves time and money but also ensures your trials are impeccably balanced and compliant with the latest FDA guidelines. Join the team when they present the poster titled:

RANDOMIZATION TESTS IN R

Date & Time: Monday, June 17th from 17:00 to 18:00 – during the PSI Meeting

Abstract:

Minimization is dynamic, covariate-adaptive, treatment-allocation procedure that can be used to achieve balance across many factors simultaneously. The flexibility of minimization is often unfortunately overlooked due to concerns regarding the complexity of implementing dynamic treatment allocation. In addition, when minimization is used as the method of randomization, a randomization test for the analysis is required. A simple R script can easily perform such a test. 

ACCESS THE FULL POSTER HERE.


Since 1991, more than 350 pharmaceutical and biotechnology companies, as well as academic cooperative groups and CROs worldwide, have relied successfully on IDDI’s expert biostatistics services, statistical consulting, operational excellence, unbiased expertise, independent data quality assessments capabilities and regulatory-compliant procedures to optimize the value of their clinical trials. 

LEARN MORE

About PSI 2024:

The annual PSI Conference attracts 350 to 450 quantitative scientists from industry, academia and regulatory/HTA agencies from the UK, Europe and beyond with an interest in statistics working in all areas of drug development and healthcare, including research, pre-clinical, production, quality control, health technology, marketing, market research, academic statisticians and consultants. This year’s Conference includes a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, and a poster session. More information here.